SciClone Pharmaceuticals (6600.HK)
|Industry||Drug Manufacturers—Specialty & Generic|
|Gross Profit (TTM)||HK$2.07B|
|Year Range||HK$5.65 - HK$12.38|
Share Price Chart
The chart shows the growth of an initial investment of HK$10,000 in SciClone Pharmaceuticals, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
SciClone Pharmaceuticals had a return of 23.76% year-to-date (YTD) and 29.71% in the last 12 months. Over the past 10 years, SciClone Pharmaceuticals had an annualized return of -22.68%, while the S&P 500 had an annualized return of 1.72%, indicating that SciClone Pharmaceuticals did not perform as well as the benchmark.
|5 years (annualized)||-22.68%||1.72%|
|10 years (annualized)||-22.68%||1.72%|
Monthly Returns Heatmap
This table presents a comparison of risk-adjusted performance metrics for SciClone Pharmaceuticals (6600.HK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
|Sharpe ratio||Sortino ratio||Omega ratio||Calmar ratio||Ulcer Index|
SciClone Pharmaceuticals granted a 7.21% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.74 per share.
The table displays the monthly dividend distributions for SciClone Pharmaceuticals. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
The Drawdowns chart displays portfolio losses from any high point along the way.
The table below shows the maximum drawdowns of the SciClone Pharmaceuticals. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the SciClone Pharmaceuticals is 68.49%, recorded on Oct 28, 2022. The portfolio has not recovered from it yet.
|-68.49%||Mar 4, 2021||408||Oct 28, 2022||—||—||—|
The current SciClone Pharmaceuticals volatility is 8.48%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.